Evidence map›Paper›PMID 25782708›Full record

ArticleThe Journal of pathology2015

Carcinogenic HPV infection in the cervical squamo-columnar junction.

Jelena Mirkovic, Brooke E Howitt, Patrick Roncarati, Stephanie Demoulin, Meggy Suarez-Carmona, Pascale Hubert, Frank D McKeon, Wa Xian, Anita Li, Philippe Delvenne and 2 more

Abstract read
In one paragraph

Article in The Journal of pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Loss of ICOSL expression in the progression to cervical carcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Jelena MirkovicDepartment of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Brooke E HowittDepartment of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Patrick RoncaratiLaboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège, Belgium.
Stephanie DemoulinLaboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège, Belgium.
Meggy Suarez-CarmonaLaboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège, Belgium.
Pascale HubertLaboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège, Belgium.
Frank D McKeonJackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Wa XianJackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Anita LiDepartment of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Philippe DelvenneLaboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège, Belgium.
Christopher P CrumDepartment of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Michael HerfsLaboratory of Experimental Pathology, GIGA-Cancer, University of Liège, Liège, Belgium.
University of Liège · BEBrigham and Women's Hospital · USJackson Laboratory · US

Funding

The squamocolumnar junction and cervical cancerR21CA173190 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRUM, CHRISTOPHER PAUL, MCKEON, FRANK D. · 2013 to 2014
$451k
NCI NIH HHS 5R21CA173190-02NCI NIH HHS R21 CA173190
6 · The paper itself

Abstract

Recent studies have suggested the involvement of a unique population of cells at the cervical squamo-columnar junction (SCJ) in the pathogenesis of early (squamous intraepithelial lesion or SIL) and advanced (squamous cell and adeno-carcinomas) cervical neoplasia. However, there is little evidence to date showing that SCJ cells harbour carcinogenic HPV or are instrumental in the initial phases of neoplasia. This study was designed to (1) determine if normal-appearing SCJ cells contained evidence of carcinogenic HPV infection and (2) trace their transition to early SIL. Sections of cervix from high-risk reproductive age women were selected and SCJ cells were analysed by using several techniques which increasingly implicated HPV infection: HPV DNA (genotyping and in situ hybridization)/RNA (PCR), immunostaining for HPV16 E2 (an early marker of HPV infection), p16(ink4), Ki67, and HPV L1 protein. In 22 cases with a history of SIL and no evidence of preneoplastic lesion in the excision specimen, HPV DNA was isolated from eight of ten with visible SCJ cells, six of which were HPV16/18 DNA-positive. In five of these latter cases, the SCJ cells were positive for p16(ink4) and/or HPV E2. Transcriptionally active HPV infection (E6/E7 mRNAs) was also detected in microdissected SCJ cells. Early squamous atypia associated with the SCJ cells demonstrated in addition diffuse p16(ink4) immunoreactivity, elevated proliferative index, and rare L1 antigen positivity. We present for the first time direct evidence that normal-appearing SCJ cells can be infected by carcinogenic HPV. They initially express HPV E2 and their progression to SIL is heralded by an expanding metaplastic progeny with increased proliferation and p16(ink4) expression. Whether certain SCJs are more vulnerable than others to carcinogenic HPV genotypes and what variables determine transition to high-grade SIL remain unresolved, but the common event appears to be a vulnerable cell at the SCJ.

Indexed as

Cell Transformation, ViralCapsid ProteinsCervix UteriCyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsDNA, ViralEpithelial CellsFemaleGenotypeHumansIn Situ HybridizationKi-67 AntigenNeoplasm ProteinsOncogene Proteins, ViralPapillomaviridaePapillomavirus InfectionsCapsid ProteinsCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsDNA, ViralHPV L1 protein, Human papillomavirusKi-67 AntigenNeoplasm Proteinsoncogene protein E2, Human papillomavirus type 1Oncogene Proteins, ViralRNA, Viralcervical intraepithelial neoplasiaHPVsquamo-columnar junction

Identifiers

PMID25782708
PMCPMC4457596
OpenAlexW2155548195

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.